Therapeutic Efficacy of Liposomal Rifabutin in a Mycobacterium avium Model of Infection
Liposomal formulations of rifabutin were developed, and the effects of some parameters on the incorporation efficiency were studied. The antimycobacterial activity of rifabutin incorporated into liposomes prepared with phosphatidylcholine and phosphatidylserine (molar ratio, 7:3) was evaluated in a...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
2000
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90080/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10952590/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.9.2424-2430.2000 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
